We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reneuron Group Plc | LSE:RENE | London | Ordinary Share | GB00BF5G6K95 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 530k | -5.41M | -0.0946 | -0.32 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/3/2016 09:52 | New to me was that at 12 minutes onwards he says the new Exosome has another possible use as they unexpectedly found it causes cancer tumour "collapse" after 18 days leaving just "cellular debris" and they have repeated this in vivo. It seems to be "programming cancer cells to adopt a normal cycle of cell death." Not many people seem to be aware of this other new treatment but it is another possible multi billion market on top of stroke and RP. He says they will trial this in humans in 2016. If it only takes three weeks to be effective they should have early results very quickly. British Biotech went from 50p to over £24 on hope for its cancer drug and its worth a bet Rene's will really work. | noteworthy5 | |
15/3/2016 09:42 | noteworthy5 Rene MAY turn out to be big winner for shareholders, me included, but the reason the shares are circa 3p now is because there is NO GUARANTEE that any one of their product evaluations will actually do what the company hopes they will do. It's a better investment than speculatively drilling for oil or mining for diamonds...but it's still a speculation. | dickbush | |
15/3/2016 09:39 | The RP treatment can get to market quickly says Michael Hunt after 5 min 30 sec | noteworthy5 | |
15/3/2016 08:47 | Being promoted elsewhere I see while locked in holders attempt to exit, not a good combination IMO. | mike111d | |
15/3/2016 08:18 | Rene's fast tracked RP treatment could be filed for market in 2018. Seems like they have another winner on top of the stroke treatments. This is going to be worth billions. | noteworthy5 | |
15/3/2016 07:48 | Could have been the US medics..... ever since watching ER I don't trust them. | small crow | |
15/3/2016 07:39 | Who says companies do not leak news to insiders ? | norbus | |
15/3/2016 07:12 | Good news. Let's hope it goes well. | small crow | |
14/3/2016 19:40 | They raised £68.4 million in a Placing last August and the Interim results in December said they had cash, cash equivalents and bank deposits at 30/9/2015 of £72.28 million. On 11/1/2016 they were awarded a further £2.1 million grant from Innovate UK to advance the exosome nanomedicine platform. This has mega bagger written all over it. If as seems possible they have one or two effective treatments for stroke the sales will be multi bllions as most people either gets a stroke, heart attack or cancer and the market is global. | noteworthy5 | |
14/3/2016 17:11 | Noteworthy, tell us about this recent placing for which there is apparently no RNS. When was it and how much was raised? | horneblower | |
14/3/2016 16:19 | noteworthy5 Shhhhhh; keep in to yourself. | norbus | |
14/3/2016 16:08 | i said what i think. RENE could be the next big winner. £70m cash on the books after a recent successful placing, broker consensus uprated to 10p, chairman recently upped his holding, and key Phase 2 stroke results and Phase 1 limb ishaemia results due in H1 2016. If as seems likely from data already released they have one or two effective treatments for stroke and its effects this will be worth billions. basically most people will either get stroke, heart attack or cancer meaning the market is global and as big as it gets. | noteworthy5 | |
14/3/2016 15:02 | Someone called Noteworthy5 is flooding the boards (well 5 or 6 posts) regarding a new placing and recent chairman share purchase. I can find no rns's or news about this. However...I do like the chart... and have bought 200k at 3.375p. | horneblower | |
14/3/2016 14:37 | SP moving slowly but surely- some news due? | stewart_25 | |
16/2/2016 13:06 | No - still can't see it. | small crow | |
16/2/2016 09:54 | If you PI's want transparency? sign this petition! | ps0u3165 | |
16/2/2016 09:24 | small crow As similar as I am to Lionel Messi? We can both wear football kit. | iomhere | |
16/2/2016 09:12 | Our CTXcryo product, US patents just applied, for could be a major factor in commercialising the breakthrough outlined in the Mirror...hopefully Woodford will have our management knocking on their door. | hlp_4u | |
16/2/2016 09:11 | Similar in what way? | small crow | |
16/2/2016 09:08 | Front page of the Mirror today....immunothera | hlp_4u | |
10/2/2016 20:33 | ReNeuron CFO Michael Hunt will be presenting to investors at the Proactive One2One Forum in Manchester on the evening of 24th February 2016. To register to attend, please click here: | aim_trader | |
08/2/2016 23:18 | link cheers ft ft | ftangftang |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions